China Journal of Leprosy and Skin Diseases ›› 2020, Vol. 36 ›› Issue (6): 335-338.doi: 10.12144/zgmfskin202006335

Previous Articles     Next Articles

The expression of PD-L1 level in cutaneous squamous cell carcinoma and keratoacanthoma

HU Jie, CHEN Wei, LU Ping, CHENG Shuanghua, LI Can   

  1. Department of Pathology, The Second Affiliated Hospital of Chengdu Medical College, National Nuclear Corporation of 416 Hospital, Chengdu 610051, China
  • Online:2020-06-15 Published:2020-06-04
  • Contact: LI Can, E-mail: sunny120li@163.com

Abstract: Objective: To detect the level of PD-L1 in the patients with cutaneous squamous cell carcinoma (cSCC) and keratoacanthoma (KA), and to analyze the correlation between PD-L1 and the differentiation of cSCC. Methods: The expression level of PD-L1 in the lesions of cSCC and KA was detected by immunohistochemical staining. Results: Fifty-six patients with cSCC and 32 patients with KA were collected. The positivity rates of PD-L1 in cSCC patients were 66.07% and 62.50% in KA patients, which was significantly higher than that in controls (9.38%) (Ps<0.01). There was no significant difference in the positivity rate of PD-L1 between cSCC and KA patients (P>0.05). The level of PD-L1 was negatively correlated with the differentiation degree of cSCC (P<0.05). Conclusion: PD-L1 may not be a useful indicator for the differnece between cSCC and KA. The level of PD-L1 was negatively correlated with the differentiation degree of cSCC.

Key words: cutaneous squamous cell carcinoma, keratoacanthoma, programmed death factor ligand-1